Miao medicine for treating hydronephrosis

Abstract

The invention discloses a Miao medicine for treating hydronephrosis. The Miao medicine for treating the hydronephrosis is prepared by formulating the following 21 Chinese herbs: rhizoma smilacinus, unprepared rehamnnia root, teasel root, plantain seed, caulis spatholobi, poria cocos, longhairy antenoron herb, ricepaperplant pith, Chinese wax gourd peel, Eclipta alba, solanum nigrum, Eucommia ulmoides, parasitic loranthus, achyranthes bidentata, polyporus umbellatus, poria cocos, rhizoma alismatis, cornus officinalis, medlar seed, Cuscuta chinensis and white peony root. A preparation method comprises the following steps: cleaning, drying and grinding the 21 Chinese herbs into blocks respectively; mixing; heating by steam or continuously decocting for basically completely extracting effective components; preparing the effective components into an extract; drying and grinding the extract; pressing the extract into tablets according to the conventional pharmaceutical process, or encapsulating to obtain the Miao medicine. The Miao medicine for treating the hydronephrosis is unique in formulation, convenient to process and significant in therapeutic effect, and is applicable for treating a patient suffering from the hydronephrosis.

Description

technical field [0001] The present invention relates to medical preparations, in particular to Miao medicine for treating hydronephrosis. Background technique [0002] hydronephrosis ( Hydronephrosis ): Hydronephrosis is dilatation of the renal pelvis and calices with atrophy of renal tissue due to obstruction of the urinary tract. Urinary tract obstruction can occur anywhere in the urinary tract and can be unilateral or bilateral. The degree of obstruction can be complete or incomplete, and can cause hydronephrosis after a certain period of time. Due to poor urine discharge, the pressure of the part above the obstruction gradually increases, and the lumen expands, which eventually leads to hydrops and dilation of the kidneys, thinning of the renal parenchyma, and decreased renal function. If bilateral obstruction occurs, uremia will have serious consequences. [0003] There are not many applications related to the treatment of hydronephrosis in the Chinese patent databas...

AI Technical Summary

Problems solved by technology

[0003] There are not many applications related to the treatment of hydronephrosis in the Chinese patent database, only No. 200810068602.5 "medicine for treating heart, lung, liver, hydronephrosis and its preparation method", No. 201010216456.3 "a drug for treating hydronephrosis" Chinese Medicine Prescriptions" and No. 201310054240.5 "A Chinese Medicine for Treating Hydronephrosis", these applications disclose some medicines prepared with Chinese medicinal materials, but their efficacy is unknown

But so far, there is no relevant patent application for Miao medicine for the treatment of hydronephrosis